NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
CYCC Cyclacel Pharmaceuticals
- 0.3174
- -0.0136-4.11%
Close Dec 20 16:00 ET
- 0.3330
- +0.0156+4.91%
Post 20:01 ET
2.00MMarket Cap-0.01P/E (TTM)
0.3500High0.3174Low392.25KVolume0.3390Open0.3310Pre Close131.13KTurnover6.32%Turnover RatioLossP/E (Static)6.29MShares4.000052wk High-2.06P/B1.97MFloat Cap0.317452wk Low--Dividend TTM6.20MShs Float2141994.0840Historical High--Div YieldTTM9.85%Amplitude0.3174Historical Low0.3340Avg Price1Lot Size
Cyclacel Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 24.01%-3.07M | -136.32%-3.08M | 92.96%-483K | 22.64%-16.11M | 24.36%-3.91M | 42.08%-4.04M | 31.85%-1.31M | -1.27%-6.86M | -12.34%-20.83M | -13.63%-5.17M |
| Net income from continuing operations | 67.56%-1.96M | 40.22%-3.26M | 49.24%-2.95M | -6.40%-22.56M | 28.95%-5.27M | -18.37%-6.03M | -19.08%-5.45M | -41.29%-5.8M | -14.85%-21.2M | -52.53%-7.42M |
| Depreciation and amortization | -85.71%1K | -75.00%2K | -75.00%2K | -3.13%31K | 0.00%8K | 0.00%7K | 0.00%8K | -11.11%8K | -25.58%32K | 14.29%8K |
| Other non cash items | 66.67%-5K | -14.29%-16K | 38.46%-16K | ---- | ---- | ---15K | ---14K | -73.33%-26K | ---- | ---- |
| Change In working capital | -175.20%-1.21M | -100.05%-2K | 257.92%2.27M | 523.22%4.94M | -47.39%976K | 171.12%1.61M | 65.72%3.79M | 52.65%-1.44M | 9.04%-1.17M | 46,275.00%1.86M |
| -Change in prepaid assets | -189.33%-67K | -74.00%1.18M | 263.70%2.02M | 224.52%4.71M | 239.26%1.35M | 103.97%75K | 41.34%4.52M | 70.09%-1.23M | 15.54%-3.78M | 46.96%-968K |
| -Change in payables and accrued expense | -174.51%-1.15M | -60.71%-1.18M | 223.30%254K | -88.51%296K | -110.78%-303K | 477.89%1.54M | 19.72%-733K | -118.99%-206K | -14.81%2.58M | 53.66%2.81M |
| -Change in other current liabilities | ---- | ---- | ---- | -272.50%-69K | ---- | ---- | ---- | ---- | -76.74%40K | 1,200.00%11K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 24.01%-3.07M | -136.32%-3.08M | 92.96%-483K | 22.64%-16.11M | 24.36%-3.91M | 42.08%-4.04M | 31.85%-1.31M | -1.27%-6.86M | -12.34%-20.83M | -13.63%-5.17M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 14.29%-6K | 0 | 0 | 0 | -50.00%-6K | 74.07%-7K | 0 |
| Net PPE purchase and sale | --0 | --0 | --0 | 14.29%-6K | --0 | --0 | --0 | -50.00%-6K | 74.07%-7K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | 14.29%-6K | --0 | --0 | --0 | -50.00%-6K | 74.07%-7K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 98.00%-1K | 12,431.37%6.29M | -58.00%-79K | -71.71%848K | 2,278.57%999K | -103.26%-50K | -103.46%-51K | 0.00%-50K | -86.21%3M | -95.26%42K |
| Net common stock issuance | ---1K | ---- | ---- | -67.21%1.05M | 1,040.22%1.05M | --0 | ---- | ---- | -81.58%3.2M | 102.53%92K |
| Cash dividends paid | --0 | --0 | --0 | 0.00%-201K | 0.00%-50K | 0.00%-50K | 0.00%-51K | 0.00%-50K | 0.00%-201K | 0.00%-50K |
| Net other financing activities | ---- | ---- | ---79K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 98.00%-1K | 12,431.37%6.29M | -58.00%-79K | -71.71%848K | 2,278.57%999K | -103.26%-50K | -103.46%-51K | 0.00%-50K | -86.21%3M | -95.26%42K |
| Net cash flow | ||||||||||
| Beginning cash position | -40.97%6M | -75.53%2.8M | -81.59%3.38M | -49.82%18.35M | -74.93%5.94M | -65.04%10.16M | -61.42%11.44M | -49.82%18.35M | 9.44%36.56M | -41.06%23.71M |
| Current changes in cash | 24.91%-3.07M | 336.36%3.21M | 91.88%-562K | 14.39%-15.27M | 43.22%-2.91M | 24.83%-4.09M | -205.41%-1.36M | -1.29%-6.92M | -662.65%-17.84M | -39.93%-5.13M |
| Effect of exchange rate changes | 137.31%50K | -103.53%-3K | -357.14%-18K | 180.16%303K | 247.44%345K | -306.15%-134K | 172.03%85K | 107.69%7K | -2,123.53%-378K | -5,950.00%-234K |
| End cash Position | -49.83%2.98M | -40.97%6M | -75.53%2.8M | -81.59%3.38M | -81.59%3.38M | -74.93%5.94M | -65.04%10.16M | -61.42%11.44M | -49.82%18.35M | -49.82%18.35M |
| Free cash flow | 24.01%-3.07M | -136.32%-3.08M | 92.97%-483K | 22.64%-16.12M | 24.36%-3.91M | 42.08%-4.04M | 31.96%-1.31M | -1.30%-6.87M | -12.21%-20.83M | -13.58%-5.17M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.